BioNexus Gene Lab (BGLC) Price to Book (2021 - 2026)

BioNexus Gene Lab has disclosed Price to Book across 6 years of filings, most recently posting 0.47 for Q2 2026.

• In Q2 2026, Price to Book fell 36.0% year-over-year to 0.47; the TTM figure through Jun 2026 stood at 0.47 (down 36.0% YoY), while the FY2025 annual figure was 0.85, up 42.01% from the prior year.
• Price to Book came in at 0.47 for Q2 2026 at BioNexus Gene Lab, down from 0.49 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 82.38 in Q2 2023 to a low of 0.47 in Q2 2026.
• Average Price to Book over 5 years is 12.88, with a median of 1.15 recorded in 2023.
• Year-over-year, Price to Book jumped 183.79% in 2023 and tumbled 98.93% in 2024.
• Over 5 years, Price to Book stood at 24.76 in 2022, then plunged by 96.08% to 0.97 in 2023, then slumped by 38.17% to 0.6 in 2024, then jumped by 42.01% to 0.85 in 2025, then sank by 45.32% to 0.47 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 0.47 in Q2 2026, 0.49 in Q1 2026, and 0.85 in Q4 2025.